Winslow, Evans & Crocker, Inc. - GW PHARMACEUTICALS PLC ownership

Quarter-by-quarter ownership
Winslow, Evans & Crocker, Inc. ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$12,000
+20.0%
1000.0%0.00%0.0%
Q3 2020$10,000
-16.7%
1000.0%0.00%
-33.3%
Q2 2020$12,000
+20.0%
1000.0%0.00%0.0%
Q1 2020$10,000
-16.7%
1000.0%0.00%0.0%
Q4 2019$12,0000.0%1000.0%0.00%0.0%
Q3 2019$12,000
-33.3%
1000.0%0.00%
-40.0%
Q2 2019$18,0000.0%1000.0%0.01%0.0%
Q1 2019$18,000
+80.0%
1000.0%0.01%
+66.7%
Q4 2018$10,000
-44.4%
1000.0%0.00%
-40.0%
Q3 2018$18,000
+28.6%
1000.0%0.01%
+25.0%
Q2 2018$14,000
-99.9%
1000.0%0.00%0.0%
Q1 2018$11,268,000
-14.6%
1000.0%0.00%0.0%
Q4 2017$13,202,000
+1199.4%
100
+900.0%
0.00%
Q3 2017$1,016,000
-88.1%
10
-88.2%
0.00%
-100.0%
Q2 2017$8,521,000
-17.1%
85
-1.2%
0.00%
-33.3%
Q1 2017$10,280,000
+8.2%
860.0%0.00%0.0%
Q4 2016$9,500,000
+107.4%
86
+72.0%
0.00%
+200.0%
Q2 2016$4,580,000
+26.9%
500.0%0.00%0.0%
Q1 2016$3,608,000
+3.9%
500.0%0.00%0.0%
Q4 2015$3,472,000500.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders